相似文献
1
Statins and the Prevention of Heart Disease.
JAMA Cardiol. 2017 Apr 1;2(4):464. doi: 10.1001/jamacardio.2016.4320.
2
[Primary prevention trials performed with statins prior to the JUPITER trial].
Turk Kardiyol Dern Ars. 2009 Apr;37 Suppl 4:14-7.
3
Primary prevention of atherosclerotic vascular disease.
SADJ. 2010 Aug;65(7):316-9.
4
Efficacy and safety of statins in the prevention of atherosclerosis in patients with systemic lupus erythematosus--a meta-analysis of randomized controlled trials.
Int J Cardiol. 2013 Jul 15;167(1):301-3. doi: 10.1016/j.ijcard.2012.09.190. Epub 2012 Oct 16.
5
Sports or statins for atheroprotection? New insight from Kruppel-like factor 2.
Cardiovasc Res. 2006 Nov 1;72(2):193-5. doi: 10.1016/j.cardiores.2006.08.016. Epub 2006 Aug 30.
6
The grapefruit-drug interaction debate: role of statins.
Am Fam Physician. 2007 Jul 15;76(2):190, 192; author reply 192.
7
The effect of statins on postprandial lipemia.
Curr Drug Targets. 2007 Apr;8(4):551-60. doi: 10.2174/138945007780362809.
8
Are statins really useless in "primary prevention"? Recent Cochrane meta-analysis revisited.
Int J Clin Pharmacol Ther. 2011 May;49(5):293-6. doi: 10.5414/cpp49293.
9
Emerging therapies for atherosclerosis prevention and management.
Cardiol Clin. 2011 Feb;29(1):123-35. doi: 10.1016/j.ccl.2010.10.003. Epub 2010 Dec 17.
10
Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence.
JAMA. 2016 Nov 15;316(19):1971-1972. doi: 10.1001/jama.2016.15212.
引用本文的文献
1
Coronary Artery Calcium Score as a Predictor of Anthracycline-Induced Cardiotoxicity: The ANTEC Study.
Pharmaceuticals (Basel). 2025 Jul 25;18(8):1102. doi: 10.3390/ph18081102.
2
Association between statin administration and -induced enteritis: a retrospective analysis of the MIMIC-IV database.
Front Pharmacol. 2025 Feb 24;16:1550378. doi: 10.3389/fphar.2025.1550378. eCollection 2025.
3
Reinforcement of Transdural Angiogenesis: A Novel Approach to Treating Ischemic Stroke With Cerebral Perfusion Impairment.
J Stroke. 2025 Jan;27(1):30-40. doi: 10.5853/jos.2024.02810. Epub 2025 Jan 31.
4
Assessing the role of statin therapy in bladder cancer: evidence from a Mendelian Randomization study.
Front Pharmacol. 2024 Jul 19;15:1427318. doi: 10.3389/fphar.2024.1427318. eCollection 2024.
5
Unusual Response of HDL-Chol Level and Body Weight to Atorvastatin: A Case Report.
Curr Health Sci J. 2024 Jan-Mar;50(1):155-157. doi: 10.12865/CHSJ.50.01.19. Epub 2024 Mar 31.
6
Evaluating Readability, Understandability, and Actionability of Online Printable Patient Education Materials for Cholesterol Management: A Systematic Review.
J Am Heart Assoc. 2024 Apr 16;13(8):e030140. doi: 10.1161/JAHA.123.030140. Epub 2024 Apr 3.
7
Potential Benefits and Risks Associated with the Use of Statins.
Pharmaceutics. 2024 Feb 1;16(2):214. doi: 10.3390/pharmaceutics16020214.
8
Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?
Cardiol Ther. 2024 Mar;13(1):39-67. doi: 10.1007/s40119-024-00353-w. Epub 2024 Feb 21.
9
Management of Coronary Artery Disease in Older Adults: Recent Advances and Gaps in Evidence.
J Clin Med. 2023 Aug 11;12(16):5233. doi: 10.3390/jcm12165233.
10
Prognostic value of coronary atherosclerosis and CAC score for the risk of chemotherapy-related cardiac dysfunction (CTRCD): The protocol of ANTEC study.
PLoS One. 2023 Aug 17;18(8):e0288146. doi: 10.1371/journal.pone.0288146. eCollection 2023.
Zotero 插件